Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

News Releases

RSS RSS Feeds
News Release Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998
DateTitle  
12/29/1998Quest Diagnostics Now Offers Meridian's New Premier Platinum HpSA -- Stomach Ulcer -- Test
CINCINNATI--(BW HealthWire)--Dec. 29, 1998--Meridian Diagnostics, Inc., (Nasdaq:KITS) announced today that its Premier Platinum HpSA (TM) stomach ulcer test is now available through Quest Diagnostics Incorporated and its network of laboratories. HpSA (Helicobacter pylori Stool Antigen), cleared for marketing by the United States Food and Drug Administration (FDA) in May 1998, is the first noninvasive direct test for H. pylori, the bacteria that causes most stomach ulcers. A more recent ... 
 Printer Friendly Version
12/22/1998New Claims for Meridian Stomach Ulcer Test Cleared By FDA
CINCINNATI--(BW HealthWire)--Dec. 22, 1998--Meridian Diagnostics, Inc., (Nasdaq:KITS) announced today that it has received clearance from the United States Food and Drug Administration (FDA) to market Premier Platinum HpSA(TM) (Helicobacter pylori Stool Antigen) to monitor therapeutic response in patients with H. pylori infection. Premier Platinum HpSA was initially cleared for marketing in May 1998 for diagnosis of H. pylori infection. H. pylori is the bacteria that causes most stomach ... 
 Printer Friendly Version
11/20/1998Meridian Diagnostics, Inc. Declares Regular Quarterly Dividend and Comments on Dividend Policy
CINCINNATI--(BW HealthWire)--Nov. 20, 1998--The Board of Directors of Meridian Diagnostics, Inc. (Nasdaq: KITS) announced declaration of the resulting quarterly cash dividend of $0.05 per share to be paid December 8, 1998 to shareholders of record on November 25, 1998. The cash dividends paid and to be paid with regard to the Company's fiscal 1998 operating results total approximately $2,876,000 which represents a dividend payout ratio of 58%. Based on the Company's fiscal 1998 ... 
 Printer Friendly Version
11/13/1998Meridian Diagnostics Announces Fourth Quarter and Fiscal Year-end Results
CINCINNATI--(BW HealthWire)--Nov. 13, 1998--Meridian Diagnostics, Inc. (Nasdaq: KITS) , Cincinnati, Ohio, today announced net sales and net earnings for the fourth fiscal quarter ended September 30, 1998 of $6,952,000 and $853,000 ($.06 per share), respectively, as compared to net sales and net earnings of $10,248,000 and $2,310,000 ($.16 per share), respectively, during the same period of the prior fiscal year. Net sales and net earnings for the fiscal year ended September 30, 1998 ... 
 Printer Friendly Version
11/6/1998Meridian Diagnostics Completes Acquisition of Gull Laboratories and Implements Cost-Cutting Plans
CINCINNATI--(BW HealthWire)--Nov. 6, 1998--Meridian Diagnostics, Inc., (Nasdaq: KITS) today announced the completion of the Gull Laboratories, Inc. (AMEX: GUL) acquisition. Gull common stock ceased trading at the close of business on the American Stock Exchange on November 5, 1998. The transaction was approved by a special meeting of the shareholders of Gull Laboratories, held November 5, 1998. The former shareholders of Gull Laboratories will receive $2.25 in cash for each common sh... 
 Printer Friendly Version
10/2/1998Meridian Diagnostics Announces Preliminary Fourth Quarter Results
CINCINNATI--(BW HealthWire)--Oct. 2, 1998--Meridian Diagnostics, Inc., (Nasdaq: KITS) today announced, based on a preliminary review of its operating results for the fourth quarter ended September 30, 1998, that it expects net sales of approximately $7.0 million, down approximately $3.0 million, over the same period of the prior fiscal year. Net earnings are estimated to be in the range of $0.7 million to $1.0 million as compared to $2.3 million for the fourth quarter of fiscal 1997. Dilu... 
 Printer Friendly Version
9/16/1998Meridian Diagnostics and Gull Laboratories Execute Definitive Agreement to Merge
CINCINNATI--(BW HealthWire)--Sept. 16, 1998--Meridian Diagnostics, Inc., (NASDAQ: KITS) today announced that it has entered into a definitive agreement to acquire Gull Laboratories, Inc. (ASE: GUL) through a merger transaction. The shareholders of Gull Laboratories will receive $2.25 in cash for each common share. Fresenius AG, the majority shareholder of Gull Laboratories, has agreed, subject to certain conditions, to vote its Gull shares in favor of the merger. The transaction is ... 
 Printer Friendly Version